Business Highlights
- USSOCOM C-130J contract progress. On
November 10, 2026 , Merlin announced it was awarded a new task order worth$8.9 million for the next phase of its C-130J autonomy program with theU.S . Special Operations Command (USSOCOM). - AFRICOM. On
November 11 2026 , Merlin announced it had been selected byU.S . Africa Command (USAFRICOM) for the initial phase of its Autonomous Casualty Evacuation (CASEVAC) Industry Technology Challenge. Included with the selection, Merlin received a$500,000 contract, which will fund a demonstration of Merlin Pilot™ autonomously executing a CASEVAC mission using a Cessna 208B Grand Caravan. - Texas Project Nexus eIPP Demonstration. In early
September 2026 , Merlin participated as an invited guest in the kickoff event for theTexas Department of Transportation’s (TxDOT) Electric Vertical Takeoff and Landing (eVTOL) Integration Pilot Program (eIPP).
“We’re advancing our defense programs in the places our customers need autonomy most,” said
Third Quarter 2026 Financial Results
- Third quarter 2026 total revenue of
$3.5 million , compared to$2.2 million in the second quarter of 2026 - Third quarter 2026 GAAP net income of
$73.8 million , compared to a loss of$(58.4) million in the second quarter of 2026 - Third quarter 2026 Adjusted EBITDA* loss of
$(24.1) million , compared to an Adjusted EBITDA loss of$(27.8) million in the second quarter of 2026 - Cash, cash equivalents, and short-term investments of
$161.6 million atSeptember 30, 2026 , compared to$183.9 million atJune 30, 2026
* For all Non-GAAP financial measures, see the reconciliation table at the end of this earnings release for further discussion
Business Outlook
Merlin’s planning process for 2027 is underway. We expect to bring our 2027 operating expenses meaningfully below our 2026 level. We will do that by concentrating our investment on the programs and customers with funded work and a clear path to revenue. Our objective is a lower, more focused cost base that preserves our balance sheet and funds our plan into 2029, without depending on capital raises.
Conference Call Details
Merlin will host a live webcast on
About Merlin
Merlin is an aerospace and defense technology company building the operating system of record for autonomous flight. Through a first-principles approach, Merlin is redefining what’s possible across aviation, aerospace, and defense with the goal of delivering full-stack autonomy for any aircraft, military or civilian, from takeoff to touchdown. The Merlin Pilot system powers a growing range of aircraft and mission profiles, proven through hundreds of autonomous flights from test facilities across the globe. With $100M+ total in IDIQ contract ceiling value under its C-130J autonomy program with USSOCOM, Merlin is advancing American leadership in autonomous aviation by helping to solve national security challenges through safe, reliable autonomy. To learn more, visit www.merlinlabs.com or follow us on X @merlinaero.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding Merlin’s expected financial performance, Merlin's 2027 annual operating plan and expected reductions in its operating expenses; the sufficiency of Merlin’s cash to fund its operating plan; expected reductions in engineering costs and regulatory timelines for future programs, expected improvements in platform performance and adaptability from operational data, expected compounding advantages across engineering, regulatory, and data dimensions, Merlin’s competitive position relative to other developers of autonomous flight technology, program milestones and execution timelines, including automated flight targets, the commercial launch and scaling of Condor, including anticipated revenue from platform adaptation, integration, and recurring software licensing arrangements, civil certification progression, including for novel AI/ML-based functionality within
Contacts
Investor Relations: investor.relations@merlinlabs.com
Media: media@merlinlabs.com
| MERLIN, INC. AND SUBSIDIARIES Condensed Consolidated Balance Sheets (UNAUDITED) (in thousands, except share amounts) | |||||||
| As of: | |||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 161,444 | $ | 59,343 | |||
| Short-term investments | 182 | 330 | |||||
| Accounts receivable, net | 1,197 | 368 | |||||
| Prepaid expenses and other current assets | 4,244 | 3,328 | |||||
| Capitalized transaction costs | — | 7,562 | |||||
| Total current assets | 167,067 | 70,931 | |||||
| Property and equipment, net | 14,398 | 7,108 | |||||
| Operating lease right-of-use assets, net | 2,268 | 979 | |||||
| Restricted cash | 2,570 | — | |||||
| Deposits | 140 | 1,564 | |||||
| Total assets | $ | 186,443 | $ | 80,582 | |||
| LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' DEFICIT | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 5,687 | $ | 3,154 | |||
| Accrued expenses | 7,450 | 7,937 | |||||
| Contract loss provision | 72 | 4,173 | |||||
| Operating lease liabilities, current | 1,235 | 657 | |||||
| Long-term debt, current portion, net ( | — | 19,271 | |||||
| Convertible promissory notes | — | 29,107 | |||||
| Total current liabilities | 14,444 | 64,299 | |||||
| Operating lease liabilities, non-current | 1,197 | 331 | |||||
| Warrant liabilities | 26,517 | 76,766 | |||||
| Long-term debt, non-current portion, net ( | — | 12,784 | |||||
| Total liabilities | 42,158 | 154,180 | |||||
| Commitments and contingencies | |||||||
| Series A Preferred Stock: | 170,577 | — | |||||
| Redeemable convertible preferred stock | — | — | |||||
| Stockholders' deficit: | |||||||
| Common stock: | 10 | 7 | |||||
| Additional paid-in capital | 599,760 | 477,448 | |||||
| Accumulated deficit | (626,062 | ) | (551,053 | ) | |||
| Total stockholders' deficit | (26,292 | ) | (73,598 | ) | |||
| Total liabilities, mezzanine equity, and stockholders' deficit | $ | 186,443 | $ | 80,582 | |||
| MERLIN, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (in thousands, except share and per share amounts) | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenue | $ | 3,461 | $ | 1,924 | $ | 6,657 | $ | 5,899 | |||||||
| Cost of revenue | 5,238 | 3,945 | 8,967 | 7,725 | |||||||||||
| Contract loss adjustments | — | — | (2,229 | ) | — | ||||||||||
| Gross loss | (1,777 | ) | (2,021 | ) | (81 | ) | (1,826 | ) | |||||||
| Operating expenses: | |||||||||||||||
| Research and development | 14,712 | 8,164 | 45,189 | 21,699 | |||||||||||
| General and administrative | 12,944 | 6,141 | 42,613 | 14,467 | |||||||||||
| Selling and marketing | 2,040 | 281 | 4,138 | 1,029 | |||||||||||
| Total operating expenses | 29,696 | 14,586 | 91,940 | 37,195 | |||||||||||
| Loss from operations | (31,473 | ) | (16,607 | ) | (92,021 | ) | (39,021 | ) | |||||||
| Other (expense) income: | |||||||||||||||
| Interest income | 1,504 | 430 | 3,468 | 862 | |||||||||||
| Interest expense | — | — | (9 | ) | (2,956 | ) | |||||||||
| Other income (expense) | 13 | 18 | (183 | ) | (193 | ) | |||||||||
| Change in fair value of warrant liabilities | 103,620 | (683 | ) | 104,030 | (4,562 | ) | |||||||||
| Change in fair value of convertible promissory notes | — | (3,118 | ) | (87,824 | ) | (3,118 | ) | ||||||||
| Loss on exchange of warrant liabilities | — | (3,320 | ) | — | (3,320 | ) | |||||||||
| Loss on issuance of financial instruments | — | (585 | ) | — | (585 | ) | |||||||||
| Loss on extinguishment of long-term debt | — | (2,157 | ) | — | (2,157 | ) | |||||||||
| Change in fair value of long-term debt | — | (672 | ) | (2,470 | ) | (672 | ) | ||||||||
| Total other income (expense) | 105,137 | (10,087 | ) | 17,012 | (16,701 | ) | |||||||||
| Income (loss) before provision for income taxes | 73,664 | (26,694 | ) | (75,009 | ) | (55,722 | ) | ||||||||
| Provision for (benefit from) income taxes | (173 | ) | 2 | — | 3 | ||||||||||
| Net income (loss) | $ | 73,837 | $ | (26,696 | ) | $ | (75,009 | ) | $ | (55,725 | ) | ||||
| Series A Preferred Stock dividends and accretion | (8,072 | ) | — | (17,713 | ) | — | |||||||||
| Income attributable to participating securities | (28,087 | ) | — | — | — | ||||||||||
| Series A Preferred Stock deemed dividend on down round | — | — | (60,864 | ) | — | ||||||||||
| Deemed dividend on exchange of redeemable convertible preferred stock | — | (345,717 | ) | — | (345,717 | ) | |||||||||
| Net income (loss) attributable to common stockholders | $ | 37,678 | $ | (372,413 | ) | $ | (153,586 | ) | $ | (401,442 | ) | ||||
| Net income (loss) per share: | |||||||||||||||
| Basic | $ | 0.37 | $ | (5.24 | ) | $ | (1.72 | ) | $ | (5.66 | ) | ||||
| Diluted | $ | 0.37 | $ | (5.24 | ) | $ | (1.72 | ) | $ | (5.66 | ) | ||||
| Weighted-average shares outstanding: | |||||||||||||||
| Basic | 101,217,672 | 71,045,916 | 89,253,660 | 70,986,625 | |||||||||||
| Diluted | 103,174,834 | 71,045,916 | 89,253,660 | 70,986,625 | |||||||||||
Non-GAAP Financial Measures
In addition to our results determined in accordance with
We believe that each of these non-GAAP financial measures provide additional metrics to evaluate our operations and, when considered with both our
The non-GAAP financial measures are presented here because we believe they are useful to investors in assessing the operating performance of our business without the effect of non-cash items, and other items as detailed below. The non-GAAP financial measures should not be considered in isolation or as alternatives to net income (loss), income (loss) from operations or any other measure of financial performance calculated and prescribed in accordance with
The following tables provide a reconciliation of EBITDA and Adjusted EBITDA to net income (loss), the most directly comparable financial measure presented in accordance with
| Three Months Ended | Nine Months Ended | ||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||
| Net income (loss) | $ | 73,837 | $ | (26,696 | ) | $ | (75,009 | ) | $ | (55,725 | ) | ||||
| Depreciation | 574 | 375 | 1,703 | 1,145 | |||||||||||
| Amortization of right-of-use assets | 320 | 183 | 871 | 549 | |||||||||||
| Interest income | (1,504 | ) | (430 | ) | (3,468 | ) | (862 | ) | |||||||
| Interest expense | — | — | 9 | 2,956 | |||||||||||
| Provision for (benefit from) income taxes | (173 | ) | 2 | — | 3 | ||||||||||
| EBITDA | 73,054 | (26,566 | ) | (75,894 | ) | (51,934 | ) | ||||||||
| Stock-based compensation | 6,375 | 526 | 12,278 | 1,472 | |||||||||||
| Equity-based payments to non-employees | 81 | — | 833 | — | |||||||||||
| Change in fair value of warrant liabilities | (103,620 | ) | 683 | (104,030 | ) | 4,562 | |||||||||
| Change in fair value of convertible promissory notes | — | 3,118 | 87,824 | 3,118 | |||||||||||
| Change in fair value of long-term debt | — | 672 | 2,470 | 672 | |||||||||||
| Loss on exchange of warrant liabilities | — | 3,320 | — | 3,320 | |||||||||||
| Loss on issuance of financial instruments | — | 585 | — | 585 | |||||||||||
| Loss on extinguishment of long-term debt | — | 2,157 | — | 2,157 | |||||||||||
| Transaction costs | — | 1,927 | 1,236 | 1,927 | |||||||||||
| Adjusted EBITDA | $ | (24,110 | ) | $ | (13,578 | ) | $ | (75,283 | ) | $ | (34,121 | ) | |||
| Three Months Ended | |||||||
| ($ in thousands) | 2026 | 2025 | |||||
| Net loss | $ | (58,427 | ) | $ | (16,296 | ) | |
| Depreciation | 712 | 389 | |||||
| Amortization of right-of-use assets | 342 | 183 | |||||
| Interest income | (1,447 | ) | (131 | ) | |||
| Interest expense | — | 1,342 | |||||
| Provision for income taxes | 125 | 1 | |||||
| EBITDA | (58,695 | ) | (14,512 | ) | |||
| Stock-based compensation | 4,608 | 433 | |||||
| Equity-based payments to non-employees | 109 | — | |||||
| Change in fair value of warrant liabilities | 26,144 | 3,925 | |||||
| Change in fair value of convertible promissory notes | — | — | |||||
| Change in fair value of long-term debt | — | — | |||||
| Transaction costs | — | — | |||||
| Adjusted EBITDA | $ | (27,834 | ) | $ | (10,154 | ) | |
Source: